Catalyst Watch: Intel earnings, drama in Davos, and the fight for Warner Bros. [Seeking Alpha]
Why ORIC Pharmaceuticals (ORIC) Is Up 36.3% After New Cancer Data And Analyst Buzz [Yahoo! Finance]
Big pharma and investors re-engage in CGTs and race to scale [Yahoo! Finance]
2 Rock-Solid Dividend Stocks to Buy for Steady Passive Income [Yahoo! Finance]
TECVAYLI® monotherapy demonstrates superior progression-free and overall survival versus standard of care as early as first relapse in patients with multiple myeloma predominantly refractory to anti-CD38 therapy and lenalidomide [Yahoo! Finance]